In laboratory settings, handling these peptides requires careful attention to avoiding contamination and ensuring that they remain sealed until reconstitution
I am very impressed with the purity and how well this works for me
Starting with Apotex but not exclusively Felix confirmed they're launching with Apo-Semaglutide Injection, the generic from Apotex which Health Canada approved on May 1, 2026
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
Important Note: IV (intravenous) administration is definitely not recommended
